Xalud Therapeutics, Inc
CAGE Code: 5MSF3
NCAGE Code: 5MSF3
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 831513770
Summary
Xalud Therapeutics, Inc is an Active Commercial Supplier with the Cage Code 5MSF3 and is tracked by Dun & Bradstreet under DUNS Number 831513770..
Address
200 Garrett St Ste S
Charlottesville VA 22902-5662
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
United States Instrument Corp Safety Software Inc Blue Ridge Numerics Inc Sprint Cellular Learning Resource Group Llc Society For Research On Biological Virginia Contractors Inc American Computer Sales, Inc. Asi Systems Intl Core Knowledge Foundation Systems Technology Inc Charlottesville Care Center Llc Silver Ring Splint Co Morris Creek Yacht Club Www Electronics Inc P O Box 168 Eiden Systems Consulting, Llc Society Of Quality Assurance Independent Battery Retailers Of Universal Test Equipment Inc Genep, Inc
Frequently Asked Questions (FAQ) for CAGE 5MSF3
- What is CAGE Code 5MSF3?
- 5MSF3 is the unique identifier used by NATO Organizations to reference the physical entity known as Xalud Therapeutics, Inc located at 200 Garrett St Ste S, Charlottesville VA 22902-5662, United States.
- Who is CAGE Code 5MSF3?
- 5MSF3 refers to Xalud Therapeutics, Inc located at 200 Garrett St Ste S, Charlottesville VA 22902-5662, United States.
- Where is CAGE Code 5MSF3 Located?
- CAGE Code 5MSF3 is located in Charlottesville, VA, USA.
Contracting History for CAGE 5MSF3 Most Recent 25 Records
- W81XWH14C0097
- Proposal Log No. 13210014 Studies To Develop A Novel Therapeutic Approach To Treat Substance Abuse And Pain
- 18 Jun 2019
- Proposal Log No. 13210014 Studies To Develop A Novel Therapeutic Approach To Treat Substance Abuse And Pain
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $2,505,217.59
- Department Of Defense (Dod)
- W81XWH14C0097
- R&D Contract Proposal Log No. 13210014 - De-Obligation Mod Aim: The Goal Of This Study Is To Move (+)-Naltrexone To Investigational New Drug (Ind) Status, Poised To Enter Clinical Trials, As This Accelerates The Testing Of (+)-Naltrexone For Indications Of Highest Relevance To The Military, Including Prevention And/Or Treatment Of Drug Abuse, And Prevention And/Or Treatment Of Chronic Pain Of Diverse Traumatic Etiologies.
- 29 Mar 2019
- R&D Contract Proposal Log No. 13210014 - De-Obligation Mod Aim: The Goal Of This Study Is To Move (+)-Naltrexone To Investigational New Drug (Ind) Status, Poised To Enter Clinical Trials, As This Accelerates The Testing Of (+)-Naltrexone For Indications Of Highest Relevance To The Military, Including Prevention And/Or Treatment Of Drug Abuse, And Prevention And/Or Treatment Of Chronic Pain Of Diverse Traumatic Etiologies.
- W4pz Usa Med Rsch Acquis Act
- Department Of Defense (Dod)
- $2,505,217.59
- Department Of Defense (Dod)